Conflicting views have been expressed regarding the advisability of mitral valvotomy in pregnancy. Little attention has been paid to the effect of pregnancy on the deterioration in cardiac status subsequent to mitral valvotomy. This study has been undertaken in an effort to clarify these two issues.
In the first part of the study the 41 patients who had the operation during pregnancy have been compared with a similar number of women who had the operation when not pregnant. Each patient in the pregnancy group was matched with a control patient in regard to criteria shown in Table I . These criteria ensure that the members of the control group before operation resemble those of the pregnancy group before conception. Differences in the two groups are said to be significant when p<005.
A previous paper (Marshall and Pantridge, 1957) reviewed 18 patients who are included in the present study. Clinical evidence of mitral incompetence, or aortic valve disease associated with cardiographic or x-ray evidence of left ventricular hypertrophy before operation 5. Cardiographic evidence of right ventricular hypertrophy (Milnor, 1957) 6. Functional disability (graded by criteria of New York Heart Association, 1939, but combining Grades I and II) comparing control patients before valvotomy with pregnant patients before conception 7. When more than one patient is available as a control, that patient whose operation occurred nearest in time to that of the pregnant patient was used and Grade IV in 7 (17%). However, all patients showed severe disability before operation, and 8 (20%) had been in acute pulmonary cedema, and 2 (5%) had had signs of congestive heart failure.
No patients had mitral incompetence or aortic valve disease producing cardiographic or x-ray evidence of left ventricular hypertrophy. Atrial fibrillation was present in 4 patients (10%);
cardiographic evidence of right ventricular hypertrophy was present in 9 (22%). In one instance cerebral embolism had occurred before pregnancy began and in another left hemiplegia developed at operation. In the control group, 2 patients (5%) had had previous cerebral emboli but no embolization occurred at the time of operation.
Among the patients with mitral valvotomy during pregnancy, 25 (610%) had had a total of 69 previous pregnancies, and in the control group 19 (46%) had had 33 pregnancies before operation. A difference is expected since many of the control group were unmarried. The stage of pregnancy at which mitral valvotomy was performed varied from 5 to 38 weeks. In 14 patients (34%) the stage of pregnancy was greater than 28 weeks. Operative findings in the two groups were similar. The mitral valve would not admit the tip of the surgeon's index finger in 27 (66%) of the pregnant women and in 30 (730 ) of the control patients.
In 3 (7%) of the pregnant women the surgeons felt a regurgitant jet at operation, and this also happened in 3 (7%) of the controls. In no case was the jet considered more than slight.
The findings at follow-up examination, which variedfrom 6 months to 10 years after operation, have been summarized in Table III which shows the percentage of patients remaining in clinical Grade I or II, calculated using the actuarial method (Berkson and Gage, 1950) .
There was one maternal death in the pregnancy group (2%). This patient, N.C., a primigravida aged 35, was admitted to hospital in congestive heart failure complicated by chest infection. She failed to respond to intensive medical therapy, and when mitral valvotomy was performed the patient was moribund. Tight stenosis was found, and the lateral commissure was split to the valve ring. She died 48 hours after operation.
Faetal or neonatal death occurred in 7 patients (17%), and premature birth may have resulted from the operation in 6 patients (15%).
There were no deaths in the follow-up period either in the pregnant group or in the control group. Table III shows the percentage of patients in each group who were in clinical Grade I or II at times of follow-up. One year after operation 95 per cent of the pregnant group were in Grade I or II compared with 98 per cent of the control group, and at six years after operation 74 per cent of the pregnant group were in Grade 1 or II compared with 78 per cent of the controls. These figures include the patient who died at operation. At no time is the difference between the two groups significant. During the time of follow-up 7 (17%) patients of the pregnancy group and 5 (12%) of the control group have needed a second operation for valvotomy.
Since their operation 13 patients (32%) whose valvotomy was performed during pregnancy have had 24 further pregnancies. In the control group 9 (22%) have had 10 pregnancies after operation.
Maternal mortality in rheumatic heart disease has fallen as antenatal care has improved. Most patients can tolerate pregnancy if they are willing to adhere to a strict medical regime in which the most important factor is rest. Alternatives to strict conservative treatment are therapeutic abortion early in pregnancy, and mitral valvotomy in cases of mitral stenosis. The indications for mitral valvotomy in pregnancy are uncertain. Burwell (1954) considers that valvotomy is "reserved for cases in which management has failed and termination is inadvisable." Mulcahy (1954) suggests that "valvotomy has an especially important place in reducing disability and invalidism" during pregnancy. Brigden (1961) writes "if it is a fact that there are indications for mitral valvotomy it makes little difference whether the patient is pregnant or not."
The arguments used by those who advise against mitral valvotomy during pregnancy are that the diagnosis of pure mitral stenosis is less accurate in these patients, and that the hmmodynamic state during pregnancy is such that the operative risk is greater than the risk of continuing the pregnancy under strict medical supervision (Gilchrist, 1963) .
In the present series, no patient was found to have significant mitral incompetence at operation and the number with minor incompetence was similar to that in the control group. Very tight mitral stenosis occurred with about equal frequency in both groups. The one maternal death occurred in a patient with congestive heart failure who had not responded to medical treatment, and whose condition was deteriorating rapidly. Mitral valvotomy earlier in pregnancy might have saved her life. We have found that in non-pregnant patients with congestive heart failure not responding to medical treatment operative mortality is very high-17 per cent (Boyle, 1960) .
The present study indicates that the risk of mitral valvotomy during pregnancy should not be greater than operation in non-pregnant women. It also indicates that diagnostic difficulties do not preclude mitral valvotomy in pregnancy. Finally, a follow-up has shown that the results of the operation during pregnancy are as good as those of the operation in non-pregnant women. (Milnor, 1957) In the second part of the study the clinical status of the 58 patients who became pregnant after mitral valvotomy was compared with that of a control group of women who did not become pregnant after operation. This control group was matched with the pregnancy group using the criteria shown in Table IV . The two groups were matched so as to be similar at the time immediately before mitral valvotomy. They were also matched so that the clinical status of a patient immediately before pregnancy was similar to that of the control.
The clinical status at the follow-up examinations after pregnancy has been recorded and compared with the findings at the equivalent follow-up periods for the control patients (Tables V and VI) . These have been expressed using the actuarial method in terms of the percentage of patients who had deteriorated from their pre-pregnancy status. Differences between the two groups were said to be significant when p<0 05. Each group contained 3 patients (50 %) aged under 20 years, 35 patients (60%) aged 21-30 years, and 20 patients (35%) aged 31-40 years at the time of mitral valvotomy. The interval between the operation and pregnancy varied from one to seven years, the average interval being 3-4 years.
Electrocardiographic evidence of right ventricular hypertrophy was present in 12 (21%) patients.
At the examination before pregnancy 50 patients (86%) were in -clinical Grade I, 7 (12%) in Grade II, and 1 (2%) in Grade III. Atrial fibrillation was present in 6 (10%). In no case was there clinical evidence of mitral incompetence or aortic valve disease associated with x-ray or cardiographic evidence of left ventricular hypertrophy. Following pregnancy 1 patient (2%) died and 5 (8%) have required a second operation. None died during pregnancy. In the control series there have been no deaths and 4 (6%) had second operations. Table V shows the findings at follow-up when deterioration is defined as that producing a downgrading of at least two functional grades, or death. Six months after pregnancy 9 per cent of patients had deteriorated and the corresponding figure for the control group is nil-a significant difference. Table VI shows the findings when less strict criteria of deterioration are observed. In this, deterioration was held to occur if the patient was down-graded at least one functional grade, or died. At six months, 24 per cent had deteriorated compared with 3 per cent of the controls. At one year after pregnancy 35 per cent had deteriorated compared with 20 per cent of the control group. These differences are significant.
Previous studies (Gorenberg and Chesley, 1958; Miller and Metcalfe, 1956; Maynard and Grover, 1960) on the effect of pregnancy on the ultimate progress in chronic rheumatic heart disease suggests that deterioration is not accelerated. These studies differ from the present one in that the patients had not had mitral valvotomy and that their clinical disability before pregnancy was greater. This optimistic view is challenged. Donzelot, Heim de Balsac, and David (1958) found that one-third of a group of patients showed deterioration one year after pregnancy and that two-thirds of them had deteriorated five years after pregnancy. These figures are similar to those of Table IV of the present study where 35 per cent had deteriorated at one year and 61 per cent at five years. They conclude that the full effect of pregnancy in chronic rheumatic heart disease cannot be assessed until several years after the event. Baker and Hancock (1960) found that out of 21 patients who became pregnant following mitral valvotomy 10 (48%) showed clinical deterioration after the pregnancy. In the present study, reviews six months and one year after pregnancy indicate that pregnancy subsequent to mitral valvotomy increases the chance of deterioration in cardiac status. The number of patients available 
